Reduced anticoagulation strategy is associated with a lower incidence of intracerebral hemorrhage in COVID-19 patients on extracorporeal membrane oxygenation

2021 ELSO Adult and Pediatric Anticoagulation Guidelines

(2022) Ali B.V. McMichael et al.   ASAIO JOURNAL

Intracranial Hemorrhages on Extracorporeal Membrane Oxygenation

(2022) Benjamin Seeliger et al.   CRITICAL CARE MEDICINE

It takes two to bleed: anticoagulation intensity and the host’s vascular susceptibility

(2022) Benjamin Seeliger et al.   INTENSIVE CARE MEDICINE

Estimating excess mortality due to the COVID-19 pandemic: a systematic analysis of COVID-19-related mortality, 2020–21

(2022) Haidong Wang et al.   LANCET

How to manage anticoagulation during extracorporeal membrane oxygenation

(2022) Jerrold H. Levy et al.   INTENSIVE CARE MEDICINE

Bleeding and thrombotic events in patients with severe COVID-19 supported with extracorporeal membrane oxygenation: a nationwide cohort study

(2022) Alexandre Mansour et al.   INTENSIVE CARE MEDICINE

Knowledge gaps and research priorities in adult veno-arterial extracorporeal membrane oxygenation: a scoping review

(2022) Senta Jorinde Raasveld et al.   Intensive Care Medicine Experimental

COVID-19: A new challenge for ECMO

(2021) Paul Nixon et al.   PERFUSION-UK

ECMO for COVID-19

(2021) Jenelle Badulak et al.   ASAIO JOURNAL

Extracorporeal membrane oxygenation in patients with severe respiratory failure from COVID-19

(2021) Shahzad Shaefi et al.   INTENSIVE CARE MEDICINE

Major bleeding complications in critically ill patients with COVID-19 pneumonia

(2021) Anne Godier et al.   JOURNAL OF THROMBOSIS AND THROMBOLYSIS

Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

(2021) Obbina Abani et al.   LANCET

Extracorporeal membrane oxygenation network organisation and clinical outcomes during the COVID-19 pandemic in Greater Paris, France: a multicentre cohort study

(2021) Guillaume Lebreton et al.   Lancet Respiratory Medicine

The authors reply

(2021) Andrew J. Doyle et al.   CRITICAL CARE MEDICINE

Therapeutic Anticoagulation with Heparin in Critically Ill Patients with Covid-19

(2021)   NEW ENGLAND JOURNAL OF MEDICINE

Coagulopathy monitoring and anticoagulation management in COVID-19 patients on ECMO: Advantages of a heparin anti-Xa-based titration strategy

(2021) Ruben Rhoades et al.   THROMBOSIS RESEARCH

Extracorporeal Life Support Organization COVID-19 Interim Guidelines

(2020) Kiran Shekar et al.   ASAIO JOURNAL

High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study

(2020) Julie Helms et al.   INTENSIVE CARE MEDICINE

The procoagulant pattern of patients with COVID‐19 acute respiratory distress syndrome

(2020) Marco Ranucci et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Endothelial cell infection and endotheliitis in COVID-19

(2020) Zsuzsanna Varga et al.   LANCET

Dexamethasone in Hospitalized Patients with Covid-19 — Preliminary Report

(2020)   NEW ENGLAND JOURNAL OF MEDICINE

Haematological characteristics and risk factors in the classification and prognosis evaluation of COVID-19: a retrospective cohort study

(2020) Danying Liao et al.   Lancet Haematology

Endotheliopathy in COVID-19-associated coagulopathy: evidence from a single-centre, cross-sectional study

(2020) George Goshua et al.   Lancet Haematology

Anti-Xa versus time-guided anticoagulation strategies in extracorporeal membrane oxygenation: a systematic review and meta-analysis

(2020) Ariane Willems et al.   PERFUSION-UK

Tocilizumab in Patients Hospitalized with Covid-19 Pneumonia

(2020) Carlos Salama et al.   NEW ENGLAND JOURNAL OF MEDICINE

Extracorporeal Membrane Oxygenation for Severe Acute Respiratory Distress Syndrome

(2018) Alain Combes et al.   NEW ENGLAND JOURNAL OF MEDICINE

Fitting Linear Mixed-Effects Models Usinglme4

(2015) Douglas Bates et al.   Journal of Statistical Software